Medtronic plc (MDT) operating KPIs
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic neuroscience Portfolio — Worldwide Revenue ($M) ($M)
Medtronic Form 8-K Quarterly World-Wide Revenue Tables & Form 10-K/10-Q Segment Disclosures
Latest, FY2026
10,287
Period ended Apr 30, 2026
Change on a year earlier
+4.5%
9,846 in FY2025
History
7 years
Since FY2020
Sources
6
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Neuroscience Portfolio — Worldwide Revenue ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2026 | Apr 30, 2026 | 10,287 | +4.5% | Medtronic SEC 8K_EARNINGS — FY2026Q4 (filed 2026-06-03) ↗ |
| FY2025 | Apr 30, 2025 | 9,846 | +4.7% | Medtronic SEC 8K_EARNINGS — FY2026Q4 (filed 2026-06-03) ↗ |
| FY2024 | Apr 30, 2024 | 9,406 | +5.0% | Medtronic SEC 8K_EARNINGS — FY2025Q4 (filed 2025-05-21) ↗ |
| FY2023 | Apr 30, 2023 | 8,959 | +2.0% | Medtronic SEC 8K_EARNINGS — FY2024Q4 (filed 2024-05-23) ↗ |
| FY2022 | Apr 30, 2022 | 8,784 | +7.2% | Medtronic SEC 8K_EARNINGS — FY2023Q4 (filed 2023-05-25) ↗ |
| FY2021 | Apr 30, 2021 | 8,195 | +6.1% | Medtronic SEC 8K_EARNINGS — FY2022Q4 (filed 2022-05-26) ↗ |
| FY2020 | Apr 30, 2020 | 7,725 | – | Medtronic SEC 8K_EARNINGS — FY2021Q4 (filed 2021-05-27) ↗ |
Breakdown
What makes up neuroscience portfolio — worldwide revenue ($m)
- Neuroscience Portfolio — Organic Revenue Growth YoY (%)3.1% · FY2026
- Neuroscience Portfolio — Foreign Currency Impact ($M)133 · FY2026
- Neuroscience Portfolio — Reported Revenue Growth YoY (%)4.5% · FY2026
- Neuroscience Portfolio — U.S. Revenue ($M)6,875 · FY2026
- Neuroscience Portfolio — International Revenue ($M)3,412 · FY2026
- Neuroscience Portfolio — Non-U.S. Developed Markets Revenue (Legacy through FY2024Q4, $M)1,739 · FY2024
- Neuroscience Portfolio — Emerging Markets Revenue (Legacy through FY2024Q4, $M)1,362 · FY2024
Cite this data
StockData. (2026). Medtronic Neuroscience Portfolio — Worldwide Revenue ($M) ($M), annual FY2020–FY2026 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/neuro-port-ww-rev
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.